A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease

NCT00784277 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

597

Enrollment

INDUSTRY

Sponsor class

Conditions

Joint Diseases
Arthritis
Osteoarthritis

Interventions

DRUG: oxycodone CR
DRUG: oxycodone IR
DRUG: Tapentadol ER (CG5503)
DRUG: Tapentadol IR (CG5503)
DRUG: Tapentadol IR (CG5503)
DRUG: placebo
DRUG: placebo

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]